Tag: 180-day exclusivity

180-Day Exclusivity and Authorized Generics: Legal Considerations in U.S. Drug Markets
Medicine

180-Day Exclusivity and Authorized Generics: Legal Considerations in U.S. Drug Markets

February 7, 2026 by Caspian Thornwood 0

The 180-day exclusivity rule was meant to reward generic drugmakers for challenging patents, but authorized generics let brand-name companies undercut them. This legal loophole is reshaping competition in the U.S. drug market.

READ MORE

First-Mover Advantage: How Generic Drug Makers Win Big by Launching First
Medicine

First-Mover Advantage: How Generic Drug Makers Win Big by Launching First

December 15, 2025 by Caspian Thornwood 9

First-mover advantage in generic drugs gives the earliest manufacturer up to 90% market share - and that lead often lasts years. Learn how the Hatch-Waxman Act, pharmacy habits, and Authorized Generics shape who wins - and who gets left behind.

READ MORE